AR025628A1 - SAPONINAS OF FOOD DEGREE AS ORAL ASSISTANTS - Google Patents

SAPONINAS OF FOOD DEGREE AS ORAL ASSISTANTS

Info

Publication number
AR025628A1
AR025628A1 ARP000104760A ARP000104760A AR025628A1 AR 025628 A1 AR025628 A1 AR 025628A1 AR P000104760 A ARP000104760 A AR P000104760A AR P000104760 A ARP000104760 A AR P000104760A AR 025628 A1 AR025628 A1 AR 025628A1
Authority
AR
Argentina
Prior art keywords
oral
saponinas
assistants
extracts
adjuvants
Prior art date
Application number
ARP000104760A
Other languages
Spanish (es)
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of AR025628A1 publication Critical patent/AR025628A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

Existe una necesidad de adyuvantes de vacuna oral eficaces. Los extractos de saponina son adyuvantes eficaces pero son toxicos, por lo que se han sugeridopreviamente saponinas purificadas. La presente proporciona saponinas de grado alimenticio parau tilizarse como adyuvantes orales. Esto evita los problemas detoxicidad de los extractos crudos y los problemas de gasto de las fracciones y extractos de saponina purificada, mientras se utilizan simultáneamente lassustancias que ya tienen laaprobaci on para la ingestion humana.There is a need for effective oral vaccine adjuvants. Saponin extracts are effective adjuvants but are toxic, so purified saponins have been previously suggested. This provides food grade saponins to be used as oral adjuvants. This avoids the toxicity problems of the crude extracts and the problems of expenditure of the purified saponin fractions and extracts, while simultaneously using the substances that already have the approval for human ingestion.

ARP000104760A 1999-09-09 2000-09-11 SAPONINAS OF FOOD DEGREE AS ORAL ASSISTANTS AR025628A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921347.2A GB9921347D0 (en) 1999-09-09 1999-09-09 Novel immunogenic compositions

Publications (1)

Publication Number Publication Date
AR025628A1 true AR025628A1 (en) 2002-12-04

Family

ID=10860653

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104760A AR025628A1 (en) 1999-09-09 2000-09-11 SAPONINAS OF FOOD DEGREE AS ORAL ASSISTANTS

Country Status (4)

Country Link
AR (1) AR025628A1 (en)
AU (1) AU7028700A (en)
GB (1) GB9921347D0 (en)
WO (1) WO2001017555A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879338B2 (en) 2003-07-21 2011-02-01 Boyce Thompson Institute For Plant Research Vectors and methods for immunization against norovirus using transgenic plants
CN101784279A (en) * 2007-06-27 2010-07-21 科洛普拉斯特公司 Treatment of urinary tract infections with a mixture of saponin and an antibiotic
WO2021102200A1 (en) * 2019-11-20 2021-05-27 Kinstate, Inc. Oral strips and methods of making same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0988053A1 (en) * 1997-06-11 2000-03-29 Aquila Biopharmaceuticals, Inc. Purified saponins as oral adjuvants

Also Published As

Publication number Publication date
WO2001017555A3 (en) 2001-11-15
GB9921347D0 (en) 1999-11-10
AU7028700A (en) 2001-04-10
WO2001017555A2 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
DK1648505T3 (en) Low toxicity quil A fraction and its use
CY1111393T1 (en) AJUGA REPTANS-BASED PLANT EXTRACTION COMPOSITION FOR HAIR PREVENTION
BR0113822A (en) Vaccine
CL2004001550A1 (en) FORMULA FOR INFANTS OR FOR NEXT STAGE OF THE GROWTH, THAT INCLUDES PROTEINS, LIPIDS, CARBOHYDRATES AND A PROBIOTICO, WHERE THE LIPID SOURCE INCLUDES AT LEAST ONE LC-PUFA, AND ITS USES.
BR0116470A (en) urea substituted imidazoquinoline ethers
HK1076033A1 (en) Formulations useful in the treatment of male and female impotence
PA8629301A1 (en) BEZEDOXIFEN ACETATE FORMULATIONS
BR0106913B1 (en) transparent bar cleaning compositions that are effective and non-irritating to the eyes
ES2163896T3 (en) COMPOSITIONS TO INCREASE THE CONCENTRATION AND / OR MOTILITY OF SPERMATOZES IN HUMANS.
AR040599A1 (en) USE OF ANECORTAVE ACETATE FOR THE PROTECTION OF VISUAL ACUTE IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
AR025628A1 (en) SAPONINAS OF FOOD DEGREE AS ORAL ASSISTANTS
ES2033570B1 (en) PROCEDURE TO FIGHT AGAINST BAD HERBS IN CORN FIELDS WITH THE AID OF A MIXTURE OF ACLONIFENO AND OTHER N-CHLOROACETAMIDE TYPE HERBICIDE.
CU22983A1 (en) VACCINE COMPOSITION AGAINST ALLERGIES AND METHOD FOR OBTAINING AND EMPLOYMENT IN THE TREATMENT OF THE SAME
DE69921486D1 (en) DEXTRAN-LEPTIN CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS
AR034451A1 (en) MICROCAPSULES FOR PROTECTION AGAINST BAD BREATH.
BR0306778A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
AR028590A1 (en) DERIVATIVES OF SULFONAMIDS; PHARMACEUTICAL COMPOSITIONS AND MANUFACTURING ITEMS THAT INCLUDE SUCH DERIVATIVES; PROCEDURE TO PREPARE THEM, PROCEDURE TO ENHANCE THE FUNCTIONS OF THE LUTAMATE RECEIVERS USING THESE DERIVATIVES, RESPECTIVELY TREATING PATIENTS AFFECTED DEPRESSION,
Jang A study on the awareness of oral health behavior and oral health education for a middle schools and high schools in Busan, Gyeongnam province
Phanuel Plant species in the folk medicine of Kit Mikayi Region, Western Kenya
SV2001000253A (en) PIRAZOLO (4,3-E) NOVEL SUBSTITUTED DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM
DK1227826T3 (en) Compositions comprising an extract of Perna canaliculus, methylsulfonylmethane and glucosamide and the use thereof
FOENUM–GRAECUM ANTIMICROBIAL ACTIVITY OF THE EXTRACTS OF SEEDS OF TRIGONELLA FOENUM–GRAECUM
Rico-Arce et al. The botanical collections of Thomas Baillie MacDougall (1895-1973); a legacy for the biodiversity of Mexico
DOP2002000406A (en) MICROCAPSULES FOR PROTECTION AGAINST BAD BREATH.
AR058225A4 (en) PUBLIC COLLECTOR CENICERO WITH INTEGRAL LIGHTING ADVERTISING SCREEN